Nearly $11.7 million has been awarded over the course of five years to The Cancer Biology Research Centre at Sanford Research from the National Institutes of Health to support clinical trial research for head, neck and paediatric cancers.
“Our hope is that this latest NIH grant allows us to improve cancer care for this region,” said Keith Miskimins, Ph.D., who is the project’s principal investigator and director of the Cancer Biology Research Centre at Sanford Research. “A grant this large positions the participating scientists well for long-term sustainability in the research world.”
“Basic research is important because it leads to discoveries that might someday be translated to patients,” said David Pearce, Ph.D., executive vice president of Sanford Research.
